Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration

Dörthe Gertzmann1, Cornelius Presek1, Anna Lena Mattes1

  • 1Department of Biochemistry and Cell Biology, Theodor Boveri Institute, Biocenter, Julius Maximilian University Würzburg, Am Hubland, 97074, Würzburg, Germany.

EMBO Reports
|July 4, 2025
PubMed

Insights

Oncogenic YAP causes replication stress by shortening G1 phase, leading to DNA damage. Targeting this vulnerability with CHK1 inhibitors offers a potential therapeutic strategy for YAP-dependent cancers.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Replication stress drives genomic instability and cancer by causing DNA damage and mutations.
  • The Hippo signaling pathway's co-activator, YAP, regulates cell growth and differentiation, but its role in generating therapy-exploitable replication stress is unknown.

Purpose of the Study:

  • To investigate whether oncogenic YAP generates replication stress that can be therapeutically exploited.
  • To elucidate the mechanisms by which YAP induces replication stress and identify potential therapeutic vulnerabilities.

Main Methods:

  • Analysis of cell cycle progression and DNA replication dynamics in cells expressing oncogenic YAP.
  • Assessment of DNA damage and sensitivity to CHK1 inhibition in YAP-expressing cells.
  • Investigation of the role of YAP-TEAD interaction, transcription, and transcription-replication conflicts (TRCs) in YAP-induced replication stress.

Main Results:

  • Oncogenic YAP shortens G1 phase via CDK4/6, causing early S-phase entry, origin underlicensing, and accelerated replication fork speed.
  • CHK1 inhibition in YAP-expressing cells leads to S-phase DNA damage, dependent on YAP-TEAD interaction, global transcription increase, and heightened TRCs.
  • YAP-induced replication stress can be alleviated by restoring G1 length or reducing YAP-driven hypertranscription.

Conclusions:

  • Oncogenic YAP induces a unique form of replication stress characterized by accelerated replication fork speed and increased transcription-replication conflicts.
  • Targeting YAP-dependent cancer cells by exploiting their vulnerability to replication stress, particularly through CHK1 inhibition or modulation of transcription, presents a promising therapeutic avenue.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K